850398 | 22:1 (Cis) PC (DEPC)
1,2-dierucoyl-sn-glycero-3-phosphocholine

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
22:1 (Cis) PC (DEPC)
1,2-dierucoyl-sn-glycero-3-phosphocholine
1,2-dierucoyl-sn-glycero-3-phosphocholine, or 22:1 (Cis) PC (DEPC), is an unsaturated phospholipid featuring 22-carbon monounsaturated acyl chains with a cis double bond. DEPC has a low phase transition temperature of about –15–20°C. For this reason, it is commonly used in liposome formulations, membrane fluidity studies, and protein-lipid interaction research.
Applications
As a crucial piece of long-circulating liposomes and nanoparticles, DEPC ensures enhanced stability and efficient drug/gene delivery. Additionally, it models highly fluid membranes by supporting lipid raft formation, domain organization, and lateral diffusion studies. Another notable characteristic of 22:1 (Cis) PC (DEPC) is its high membrane flexibility, which helps facilitate ion channel studies, transmembrane protein integration, and structural lipid research.
Additionally, this phospholipid helps understand membrane mechanics, making it critical in bilayer fusion, permeability studies, and vesicle stability research.
Packaging
Avanti Research™ offers 22:1 (Cis) PC (DEPC) in 25mg packaging in powder and chloroform to accommodate a variety of research applications.
Our commitment to uncompromising purity ensures your research is conducted with the highest quality phospholipids for breakthrough results!
As a Croda Pharma brand, Avanti Research is your partner from research innovation to GMP excellence. Visit Croda Pharma for GMP-certified DEPC and other pharmaceutical-grade lipid solutions to advance your research to the next level.
CAS Registry Number is a Registered Trademark of the American Chemical Society
PC(22:1(13Z)/22:1(13Z))
DEPC
730398
Greathouse D, Lipinski K, McKay MJ, Afrose F, Martfeld AN, Koeppe RE 2nd. Influence of Lipid Saturation, Hydrophobic Length and Cholesterol on Double-Arginine-Containing Helical Peptides in Bilayer Membranes. Chembiochem. 2019 May 31. doi: 10.1002/cbic.201900282. [Epub ahead of print]
PubMed ID: 31150136Holopainen M, Colas RA, Valkonen S, Tigistu-Sahle F, Hyvärinen K, Mazzacuva F, Lehenkari P, Käkelä R, Dalli J, Kerkelä E, Laitinen S. Polyunsaturated fatty acids modify the extracellular vesicle membranes and increase the production of proresolving lipid mediators of human mesenchymal stromal cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun 15;1864(10):1350-1362. doi: 10.1016/j.bbalip.2019.06.010. [Epub ahead of print]
PubMed ID: 31207356Gutzeit VA, Thibado J, Stor DS, Zhou Z, Blanchard SC, Andersen OS, Levitz J. Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor. Elife. 2019 Jun 7;8. pii: e45116. doi: 10.7554/eLife.45116.
PubMed ID: 31172948Forest A, Ruiz M, Bouchard B, Boucher G, Gingras O, Daneault C, Robillard Frayne I, Rhainds D, Consortium TI, Genetics Consortium TNI, Tardif JC, Rioux JD, Des Rosiers C. A Comprehensive and Reproducible Untargeted Lipidomic Workflow Using LC-QTOF Validated for Human Plasma Analysis. J Proteome Res. 2018 Sep 26. doi: 10.1021/acs.jproteome.8b00270. [Epub ahead of print]
PubMed ID: 30256116- Certificate of Analysis (Lot No. 850398C-25MG-A-042 and 5668CJA042)
- Certificate of Analysis (Lot No. 850398P-25MG-A-042 and 5668PJA042)
- Certificate of Analysis (Lot No. 850398P-25MG-B-042 and 5668PJB042)
- Certificate of Analysis (Lot No. 850398P-25MG-A-044 and 5668PJA044)
- Certificate of Analysis (Lot No. 850398C-25MG-A-044 and 5668CJA044)
- Certificate of Analysis (Lot No. 850398P-25MG-B-044 and 5668PJB044)
- Certificate of Analysis (Lot No. 850398P-25MG-C-044 and 5668PJC044)
- Certificate of Analysis (Lot No. 850398C-25MG-B-044 and 5668CJB044)
- Certificate of Analysis (Lot No. 850398C-25MG-C-044 and 5668CJC044)
- Certificate of Analysis (Lot No. 850398C-25MG-D-044 and 5668CJD044)
- Certificate of Analysis (Lot No. 850398C-25MG-E-044 and 5668CJE044)
- Certificate of Analysis (Lot No. 850398C-25MG-A-051 and 5668CJA051)
- Certificate of Analysis (Lot No. 850398C-25MG-B-051 and 5668CJB051)
- Certificate of Analysis (Lot No. 850398C-25MG-C-051 and 5668CJC051)
- Certificate of Analysis (Lot No. 850398P-25MG-A-051 and 5668PJA051)
- Certificate of Analysis (Lot No. 850398C-25MG-D-051 and 5668CJD051)
- Certificate of Analysis (Lot No. 850398P-25MG-B-051 and 5668PJB051)
- Certificate of Analysis (Lot No. 850398P-CONF-A-051 and 5668PWA051)
- Certificate of Analysis (Lot No. 850398P-25MG-C-051 and 5668PJC051)